Looking to diversify beyond LABD? The ETFs below have the lowest correlation with LABD — they tend to move on their own, which can help reduce risk when the rest of your portfolio drops. The stock ideas table highlights individual companies that behave independently from LABD.
Best Diversifiers for LABD
2072 ETFs have low correlation with LABD (below 0.3), 2024 of which are negatively correlated. The least correlated is SPDR S&P Biotech ETF (XBI) (Health & Biotech Equities) with a 1Y correlation of -1.00, roughly unchanged from -1.00 over 5 years.
| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | -1.00 | -1.00 | -1.00 | 90 | Health & Biotech Equities | LABD vs XBI | |
| Direxion Daily S&P Biotech Bull 3x Shares | -1.00 | -1.00 | -1.00 | 90 | Leveraged Equities | LABD vs LABU | |
| ALPS Medical Breakthroughs ETF | -0.95 | -0.93 | -0.95 | 91 | Health & Biotech Equities | LABD vs SBIO | |
| ProShares Ultra Nasdaq Biotechnology | -0.92 | -0.92 | -0.91 | 76 | Leveraged Equities | LABD vs BIB | |
| Virtus LifeSci Biotech Clinical Trials ETF | -0.92 | -0.92 | -0.94 | 94 | Health & Biotech Equities | LABD vs BBC |
See all 2072 diversifiers for LABD
To view more results, upgrade your current subscription plan.
Diversification Analysis
Build a portfolio that complements LABD
Add LABD to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with LABD